sellWeak10b5-1 plan
Thomas J Klima sold $3,726 of BLUE
See Remarks at bluebird bio, Inc.. 3,834 shares at an average of $0.97, traded Jun 3, 2024, filed Jun 4, 2024.
Warning score
0Value
$3,726
3,834 shares
Holdings after
121,006
-3% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- 0Trade size$4k at market
- 0Share of holdings soldSold 3.1% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001562180-24-004633, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 3, 2024 | SOpen-market sale Common Stock10b5-1 | -3,834 | $0.97 | $3,726 | 121,006 | Jun 4, 2024 |
Related signals
Other insiders at bluebird bio, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 3Weak | bluebird bio, Inc. | Richard A Colvin Chief Medical Officer | $2,289 584 shares | -7% | |
| 3Weak | bluebird bio, Inc. | Thomas J Klima See Remarks | $1,960 500 shares | -6% | |
| 3Weak | bluebird bio, Inc. | Richard A Colvin Chief Medical Officer | $473 64 shares | -1% | |
| 3Weak | bluebird bio, Inc. | Thomas J Klima See Remarks | $902 122 shares | -1% | |
| 0Weak | bluebird bio, Inc. | Richard A Colvin Chief Medical Officer | $176 19 shares | -0% | |
| 3Weak | bluebird bio, Inc. | Richard A Colvin Chief Medical Officer | $1,178 2,824 shares | -2% | |
| 13Weak | bluebird bio, Inc. | Andrew Obenshain President and CEO | $405 971 shares | -0% | |
| 3Weak | bluebird bio, Inc. | Thomas J Klima See Remarks | $529 1,006 shares | -1% | |
| 13Weak | bluebird bio, Inc. | Andrew Obenshain President and CEO | $18k 34,780 shares | -8% | |
| 10Weak | bluebird bio, Inc. | Richard A Colvin Chief Medical Officer | $10k 6,770 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.